RxDoctor Payments Data

Jayant Agarwal

Plastic and Reconstructive Surgery · Salt Lake City, UTNPI 1508878372

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,570 of the $33,358 with a category attached, or 79.7%. Encore Medical, LP accounts for 85.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $13,784 and has fallen 91.3% since, to $1,195 in 2025.

$33,358in general payments, 2019–2025

Across 60 payments — averaging $555.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$29K
  • Integra Lifesciences Corporation$2K
  • Mentor Worldwide LLC$665
  • AbbVie$426
  • Stryker$317
  • Davol Inc.$306
  • plus $1K from 11 others
$566,707in research payments, 2019–2025

Across 14 payments — averaging $40,479 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • KCI USA, Inc.$290K
  • Gilead$120K
  • Solventum Corporation$97K
  • Grifols Biologicals LLC$61K

What the payments were for

  • Consulting fees$26,57080%
  • Travel & lodging$3,61311%
  • Food & beverage$3,17510%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$29,817
Medicare patients
24
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →